- Home
- PRPO vs BOF Comparison
PRPO vs BOF Comparison
Compare PRPO & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- BOF
- Stock Information
- Founded
- PRPO N/A
- BOF 2017
- Country
- PRPO United States
- BOF United States
- Employees
- PRPO N/A
- BOF N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- BOF Packaged Foods
- Sector
- PRPO Industrials
- BOF Consumer Staples
- Exchange
- PRPO Nasdaq
- BOF Nasdaq
- Market Cap
- PRPO 32.4M
- BOF 27.6M
- IPO Year
- PRPO N/A
- BOF 2023
- Fundamental
- Price
- PRPO $20.50
- BOF $3.13
- Analyst Decision
- PRPO
- BOF
- Analyst Count
- PRPO 0
- BOF 0
- Target Price
- PRPO N/A
- BOF N/A
- AVG Volume (30 Days)
- PRPO 11.3K
- BOF 3.7M
- Earning Date
- PRPO 11-17-2025
- BOF 11-12-2025
- Dividend Yield
- PRPO N/A
- BOF N/A
- EPS Growth
- PRPO N/A
- BOF N/A
- EPS
- PRPO N/A
- BOF N/A
- Revenue
- PRPO $21,242,000.00
- BOF $10,179,595.00
- Revenue This Year
- PRPO N/A
- BOF N/A
- Revenue Next Year
- PRPO N/A
- BOF N/A
- P/E Ratio
- PRPO N/A
- BOF N/A
- Revenue Growth
- PRPO 27.05
- BOF 95.18
- 52 Week Low
- PRPO $3.90
- BOF $1.53
- 52 Week High
- PRPO $22.38
- BOF $3.37
- Technical
- Relative Strength Index (RSI)
- PRPO 51.49
- BOF 58.10
- Support Level
- PRPO $19.00
- BOF $2.79
- Resistance Level
- PRPO $21.00
- BOF $3.30
- Average True Range (ATR)
- PRPO 1.05
- BOF 0.30
- MACD
- PRPO -0.16
- BOF -0.01
- Stochastic Oscillator
- PRPO 27.44
- BOF 58.99
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.